
Walden Robotics has launched from stealth with $300m and a $1.1bn valuation. The Toyota spin-out builds humanoids for factories, and it left off the legs on purpose. “If you listen to the people on the factory floor, they aren’t ready, and they don’t w…

No name. No product. No confirmed funding. And, possibly, a $2bn price tag. That is the shape of the newest bet in AI drug discovery. Miles Wang, a researcher at OpenAI, is leaving to start his own company, TechCrunch reported. He is in talks to raise …

Emergent’s vibe coding platform hit a $1.5bn valuation a year after launch. Its founder says most businesses do not need software, they need a way to turn how they work into it. “Most businesses don’t need any software. They need a way to turn how they…

Chai Discovery’s $400m raise triples its value to $3.8bn in seven months. It is the latest sign that AI drug discovery has moved from promise to deployment. AI drug discovery just minted another fast-rising star. Chai Discovery has raised a $400m Serie…

China’s biggest memory chipmaker is about to test the public markets. ChangXin Memory Technologies, known as CXMT, has priced its Shanghai IPO at 8.66 yuan ($1.28) a share, the South China Morning Post reported. The sale will raise about 57.9 billion y…

DeepSeek is getting ready to go public. The Chinese AI lab has started laying the groundwork for an initial public offering, according to Bloomberg. It could file as soon as this year, with a debut targeted for 2027. First, though, it wants to raise mo…

London fintech Velocity has raised a $38 million Series A to help businesses move money with stablecoins. The Velocity Series A, led by Dragonfly and FirstMark, brings the two-year-old company’s total funding to nearly $50 million. Velocity builds trea…